Login with your work email address to view charts. No credit card required.
| Art Unit: | 1682 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1680 — Nucleic acid assay, Combinatorial and Computational Chemistry, Combination Biology and Computer Science |
| Classes: |
435 — Chemistry: molecular biology and microbiology 506 — Combinatorial chemistry technology: method, library, apparatus 536 — Organic compounds -- part of the class 532-570 series 514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions 702 — Data processing: measuring, calibrating, or testing |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr Biolgy |
| Service: | 21 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 50% over 323 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 80th
|
With Examiner Salmon, you have a 50% chance of getting an issued patent by 3 years after the first office action. Examiner Salmon is a harder examiner and in the 80th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Salmon, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Salmon's grant rate is higher than that of Art Unit 1682 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Salmon | 2.4 |
| Art Unit 1682 | 2.4 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.